
Biocept BIOC
Quartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Biocept P/CF 2011-2026 | BIOC
P/CF Jährlich Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.447 | 11.2 | -3.37 | -0.269 | -0.234 | -0.44 | -0.87 | -1.53 | -0.562 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11.2 | -3.37 | 0.388 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.19 | 0.5 % | $ 174 M | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 117.7 | 2.28 % | $ 35.8 B | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 16.76 | 4.42 % | $ 893 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.43 | 4.38 % | $ 1.9 M | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 23.18 | 0.22 % | $ 644 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 177.87 | 1.25 % | $ 8.82 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 498.89 | 1.09 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
23.3 | $ 194.47 | 2.58 % | $ 139 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.59 | 5.4 % | $ 425 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
284 | $ 7.95 | 3.38 % | $ 1.02 B | ||
|
Illumina
ILMN
|
19.6 | $ 126.18 | 4.34 % | $ 20.1 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 15.34 | 6.31 % | $ 464 M | ||
|
Guardant Health
GH
|
-72.7 | $ 80.98 | 3.03 % | $ 10.2 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.69 | 0.15 % | $ 279 M | ||
|
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.77 | 2.79 % | $ 89.9 K | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.07 | -3.05 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 28.52 | 0.76 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 110.04 | 3.02 % | $ 9.08 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.64 | 0.01 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 263.77 | 1.09 % | $ 21.9 B | ||
|
Natera
NTRA
|
-12.3 | $ 199.3 | 3.25 % | $ 19.6 B | ||
|
Celcuity
CELC
|
-35 | $ 119.06 | 1.64 % | $ 5.57 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 80.85 | 0.32 % | $ 5.46 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neuronetics
STIM
|
-3.98 | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 190.84 | -0.36 % | $ 21.2 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.32 | -1.01 % | $ 2.02 B | ||
|
ENDRA Life Sciences
NDRA
|
-0.706 | $ 4.97 | 0.61 % | $ 3.91 M | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M |